Drug profile · INN
ephedrine sulfate
EPHEDRINE SULFATE
ephedrine sulfate (EPHEDRINE SULFATE) is a adrenergic receptor agonist. Associated with Amneal Pharma Europe Ltd. Route of administration: intravenous. Current US regulatory status: approved.
Drug details — ephedrine sulfate
- US status
- approved
- Class
- —
- Route
- INTRAVENOUS
- Patents
- 0
- Programs
- 0
- Data quality
- 0.89
Quick answer
ephedrine sulfate (EPHEDRINE SULFATE) is a adrenergic receptor agonist. Associated with Amneal Pharma Europe Ltd. Route of administration: intravenous. Current US regulatory status: approved.
Key facts
Mechanism of action
Adrenergic receptor agonist
Primary target: Adrenergic receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is ephedrine sulfate?
ephedrine sulfate (EPHEDRINE SULFATE) is a adrenergic receptor agonist. Associated with Amneal Pharma Europe Ltd. Route of administration: intravenous. Current US regulatory status: approved.
What is the brand name for ephedrine sulfate?
EPHEDRINE SULFATE is a marketed brand name for ephedrine sulfate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of ephedrine sulfate?
ephedrine sulfate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.